Biotech News

Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026

Clover Health (CLOV)Clover Health2026-04-01 12:30 ESTCompany update

WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Peter Kuipers is stepping down as the Chief

Clover Health

Medicare Advantage Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care. Clover Assistant Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates...

Recent company news

CLOVClover Health2026-08-05 20:05 EST

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

CLOVClover Health2026-05-06 20:05 EST

Clover Health Reports First Quarter 2026 Results

Stock data

Close: 4.15 USD
Market cap: 1.96B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026

Related news

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026